Literature DB >> 12741681

The vascular phenotype of melanoma metastasis.

Omaida C Velazquez1, Meenhard Herlyn.   

Abstract

Melanoma cells but not normal melanocytes share important cell surface molecules with endothelial cells. From this observation has grown our hypothesis that melanoma and endothelial cells use the same cell surface molecules for invasion but that their intracellular signaling is different allowing the malignant cells dominance over the normal cells. Stromal fibroblasts and endothelial cells communicate with metastatic cells through an interactive network of cell-cell and cell-matrix signaling. Fibroblasts induce capillary-like differentiation of microvascular endothelial cell monolayers through cell-cell contact and soluble factors. It is then hypothesized that normal cellular precursors are recruited from the bone marrow to the site of a growing melanoma metastasis. Thus pathways for angiogenesis and vasculogenesis are guided through the cooperation of fibroblasts and melanoma cells perpetuated by the dominance of the metastatic melanoma cells.

Entities:  

Mesh:

Year:  2003        PMID: 12741681     DOI: 10.1023/a:1022987201264

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  10 in total

1.  Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells.

Authors:  Junji Morokuma; Douglas Blackiston; Dany S Adams; Guiscard Seebohm; Barry Trimmer; Michael Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-17       Impact factor: 11.205

2.  Melanoma--the pieces of the puzzle finally start coming together! Preface.

Authors:  Alan Spatz; Alexander M M Eggermont
Journal:  Mol Oncol       Date:  2011-04-03       Impact factor: 6.603

3.  Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis.

Authors:  Hua Yang; Hans E Grossniklaus
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

4.  Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.

Authors:  Megan J Stine; C Joanne Wang; Whei F Moriarty; Byungwoo Ryu; Raymond Cheong; William H Westra; Andre Levchenko; Rhoda M Alani
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

Review 5.  Interface of signal transduction inhibition and immunotherapy in melanoma.

Authors:  Amber L Shada; Kerrington R Molhoek; Craig L Slingluff
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

6.  Functional erythropoietin autocrine loop in melanoma.

Authors:  Suresh M Kumar; Geza Acs; Dong Fang; Meenhard Herlyn; David E Elder; Xiaowei Xu
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

8.  Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma.

Authors:  Zoe N Demou; Mary J C Hendrix
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

Review 9.  Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets.

Authors:  Daniel E Abbott; Lynne-Marie Postovit; Elisabeth A Seftor; Naira V Margaryan; Richard E B Seftor; Mary J C Hendrix
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 6.692

10.  Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma.

Authors:  Steffen Eikenberry; Craig Thalhauser; Yang Kuang
Journal:  PLoS Comput Biol       Date:  2009-04-24       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.